|
1
|
Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.
|
J Med Chem
|
2013
|
0.97
|
|
2
|
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
|
J Med Chem
|
2014
|
0.93
|
|
3
|
Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.
|
J Med Chem
|
2014
|
0.83
|
|
4
|
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.
|
J Med Chem
|
2014
|
0.82
|